StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

(+)-Lariciresinol → (+)-Pinoresinol (+)-Lariciresinol

HRID 321912
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 321912
[CH3:1][O:2][C:3]1[CH:4]=[C:5]([C@H:10]2[O:17][CH2:16][C@H:15]3[C@@H:11]2[CH2:12][O:13][C@H:14]3[C:18]2[CH:19]=[CH:20][C:21]([OH:26])=[C:22]([O:24][CH3:25])[CH:23]=2)[CH:6]=[CH:7][C:8]=1[OH:9].[CH3:27][O:28][C:29]1[CH:30]=[C:31]([CH2:36][C@@H:37]2[C@H:41]([CH2:42][OH:43])[C@@H:40]([C:44]3[CH:45]=[CH:46][C:47]([OH:52])=[C:48]([O:50][CH3:51])[CH:49]=3)[O:39][CH2:38]2)[CH:32]=[CH:33][C:34]=1[OH:35]>CO>[CH3:1][O:2][C:3]1[CH:4]=[C:5]([C@@H:10]2[O:17][CH2:16][C@@H:15]3[C@H:11]2[CH2:12][O:13][C@H:14]3[C:18]2[CH:19]=[CH:20][C:21]([OH:26])=[C:22]([O:24][CH3:25])[CH:23]=2)[CH:6]=[CH:7][C:8]=1[OH:9].[CH3:27][O:28][C:29]1[CH:30]=[C:31]([CH2:36][C@@H:37]2[C@H:41]([CH2:42][OH:43])[C@@H:40]([C:44]3[CH:45]=[CH:46][C:47]([OH:52])=[C:48]([O:50][CH3:51])[CH:49]=3)[O:39][CH2:38]2)[CH:32]=[CH:33][C:34]=1[OH:35]
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

4

Edukt 2

HCID 332427(+)-LariciresinolHCID 637584Epipinoresinol2×

Produkt 1

HCID 131722472(+)-Pinoresinol (+)-Lariciresinol

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 887MethanolLösungsmittel

Reaktionsbedingungen

Temperatur
30 °C

Versuchsvorschrift

Enzyme Assays. Pinoresinol and lariciresinol reductase activities were assayed by monitoring the formation of [3H]lariciresinol and [3H]secoisolariciresinol as set forth in Example 8, with the following modifications. Briefly, each assay for pinoresinol reductase activity consisted of (±)-pinoresinols (5 mM in MeOH, 20 μl) and the enzyme preparation (i.e., total protein extract from E. coli, 210 μl). The enzymatic reaction was initiated by addition of [4R-3H]NADPH (10 mM, 6.79 kBq/mmol in distilled H2O, 20 μl). After 3 hour incubation at 30° C. with shaking, the assay mixture was extracted with EtOAc (500 μl) containing (±)-lariciresinols (20 μg) and (±)-secoisolariciresinols (20 μg) as radiochemical carriers. After centrifugation (13,800×g, 5 min), the EtOAc solubles were removed and the extraction procedure was repeated. For each assay, the EtOAc solubles were combined with an aliquot (100 μl) removed for determination of its radioactivity using liquid scintillation counting. The remainder of the combined EtOAc solubles was evaporated to dryness in vacuo, reconstituted in MeOH/H2O (30:70, 100 μl) and subjected to reversed phase and chiral column HPLC.

Aufarbeitung

  1. customthe enzyme preparation (i.e., total protein extract from E. coli, 210 μl)
  2. customThe enzymatic reaction
  3. extractionthe assay mixture was extracted with EtOAc (500 μl)
  4. additioncontaining (±)-lariciresinols (20 μg) and (±)-secoisolariciresinols (20 μg) as radiochemical carriers
  5. customAfter centrifugation (13,800×g, 5 min), the EtOAc solubles were removed
  6. extractionthe extraction procedure
  7. customremoved for determination of its radioactivity
  8. customThe remainder of the combined EtOAc solubles was evaporated to dryness in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-9d721d3ed5ba4093b69fe87f7dc21f3e
Quelldatensatz
uspto-grants-2001_04
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US06210942B1

Notizen zur Reaktion

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion